- Home
- GIC vs AUPH Comparison
GIC vs AUPH Comparison
Compare GIC & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIC
- AUPH
- Stock Information
- Founded
- GIC 1949
- AUPH 1993
- Country
- GIC United States
- AUPH Canada
- Employees
- GIC N/A
- AUPH N/A
- Industry
- GIC Industrial Machinery/Components
- AUPH Biotechnology: Pharmaceutical Preparations
- Sector
- GIC Industrials
- AUPH Health Care
- Exchange
- GIC Nasdaq
- AUPH Nasdaq
- Market Cap
- GIC 860.9M
- AUPH 999.8M
- IPO Year
- GIC 1995
- AUPH 1999
- Fundamental
- Price
- GIC $21.46
- AUPH $7.75
- Analyst Decision
- GIC
- AUPH Strong Buy
- Analyst Count
- GIC 0
- AUPH 2
- Target Price
- GIC N/A
- AUPH $11.50
- AVG Volume (30 Days)
- GIC 138.0K
- AUPH 1.3M
- Earning Date
- GIC 04-29-2025
- AUPH 05-01-2025
- Dividend Yield
- GIC 4.84%
- AUPH N/A
- EPS Growth
- GIC N/A
- AUPH N/A
- EPS
- GIC 1.58
- AUPH 0.04
- Revenue
- GIC $1,315,900,000.00
- AUPH $235,133,000.00
- Revenue This Year
- GIC $2.52
- AUPH $11.86
- Revenue Next Year
- GIC $4.30
- AUPH $24.96
- P/E Ratio
- GIC $13.67
- AUPH $193.75
- Revenue Growth
- GIC 3.27
- AUPH 33.97
- 52 Week Low
- GIC $20.79
- AUPH $4.71
- 52 Week High
- GIC $41.38
- AUPH $10.67
- Technical
- Relative Strength Index (RSI)
- GIC 40.65
- AUPH 46.63
- Support Level
- GIC $20.79
- AUPH $7.59
- Resistance Level
- GIC $22.77
- AUPH $7.83
- Average True Range (ATR)
- GIC 0.89
- AUPH 0.35
- MACD
- GIC 0.02
- AUPH -0.02
- Stochastic Oscillator
- GIC 31.46
- AUPH 65.84
About GIC Global Industrial Company
Global Industrial Co is a value-added industrial distributor. The company distributes a wide range of industrial and maintenance, repair, and operations (MRO) products to customers across North America, including storage and shelving, safety and security, carts and trucks, HVAC and fans, furniture and decor, material handling, janitorial and facility maintenance, workbenches and shop desks, tools and instruments, plumbing and pumps, office and school supplies, packaging and shipping, lighting and electrical, food service and retail, medical and laboratory, motors and power transmission, building supplies, machining, fasteners and hardware, vehicle maintenance, and raw materials.
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.